MONICA COMAS: Open Payments
NPI 1831768225 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,407 in 40 payments from 9 companies in 2025. Trend: 2023 $1,988 · 2024 $1,729 · 2025 $1,407
Food & beverage: $1,407
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 17 | $622 |
| Janssen Biotech, Inc. | 6 | $210 |
| Autolus Inc | 1 | $170 |
| ABBVIE INC. | 7 | $167 |
| SANOFI-AVENTIS U.S. LLC | 4 | $112 |
| GENZYME CORPORATION | 2 | $59 |
| Genentech USA, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: Yescarta, RYBREVANT, IMBRUVICA, REZUROCK, SARCLISA, EPKINLY, DARZALEX, Columvi.
Industry payments across NY — which companies pay providers there.
